Do investors have a safe investment in Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX)?
The price of Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) shares last traded on Wall Street rose 17.29% to $30.59. Based on available information, 10 analysts follow Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $60.00 and a low of […]
